nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—Ethinyl Estradiol—osteoporosis	0.291	1	CrCtD
Etonogestrel—SHBG—osteoporosis	0.114	0.597	CbGaD
Etonogestrel—ESR1—osteoporosis	0.0767	0.403	CbGaD
Etonogestrel—SHBG—Estropipate—osteoporosis	0.0448	0.209	CbGbCtD
Etonogestrel—ESR1—Estropipate—osteoporosis	0.0324	0.151	CbGbCtD
Etonogestrel—SHBG—Ethinyl Estradiol—osteoporosis	0.0289	0.135	CbGbCtD
Etonogestrel—ESR1—Raloxifene—osteoporosis	0.0216	0.101	CbGbCtD
Etonogestrel—ESR1—Ethinyl Estradiol—osteoporosis	0.0209	0.0974	CbGbCtD
Etonogestrel—SHBG—Estradiol—osteoporosis	0.0186	0.0868	CbGbCtD
Etonogestrel—Quinestrol—Estropipate—osteoporosis	0.0181	0.0824	CrCrCtD
Etonogestrel—Mestranol—Estropipate—osteoporosis	0.0181	0.0824	CrCrCtD
Etonogestrel—Ethinyl Estradiol—Estropipate—osteoporosis	0.0173	0.0785	CrCrCtD
Etonogestrel—Desogestrel—Ethinyl Estradiol—osteoporosis	0.0156	0.0708	CrCrCtD
Etonogestrel—ESR1—Conjugated Estrogens—osteoporosis	0.0153	0.0715	CbGbCtD
Etonogestrel—Mestranol—Conjugated Estrogens—osteoporosis	0.0137	0.0625	CrCrCtD
Etonogestrel—Quinestrol—Conjugated Estrogens—osteoporosis	0.0137	0.0625	CrCrCtD
Etonogestrel—ESR1—Estradiol—osteoporosis	0.0134	0.0628	CbGbCtD
Etonogestrel—Ethinyl Estradiol—Conjugated Estrogens—osteoporosis	0.0131	0.0595	CrCrCtD
Etonogestrel—Norelgestromin—Ethinyl Estradiol—osteoporosis	0.0122	0.0553	CrCrCtD
Etonogestrel—Mestranol—Estradiol—osteoporosis	0.0118	0.0538	CrCrCtD
Etonogestrel—Quinestrol—Estradiol—osteoporosis	0.0118	0.0538	CrCrCtD
Etonogestrel—Quinestrol—Ethinyl Estradiol—osteoporosis	0.0115	0.0525	CrCrCtD
Etonogestrel—Mestranol—Ethinyl Estradiol—osteoporosis	0.0115	0.0525	CrCrCtD
Etonogestrel—Ethinyl Estradiol—Estradiol—osteoporosis	0.0113	0.0512	CrCrCtD
Etonogestrel—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.0101	0.0457	CrCrCtD
Etonogestrel—Danazol—Ethinyl Estradiol—osteoporosis	0.00929	0.0422	CrCrCtD
Etonogestrel—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00808	0.0367	CrCrCtD
Etonogestrel—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.00663	0.0301	CrCrCtD
Etonogestrel—Testosterone—Estradiol—osteoporosis	0.00605	0.0275	CrCrCtD
Etonogestrel—CYP3A4—Estropipate—osteoporosis	0.00332	0.0155	CbGbCtD
Etonogestrel—CYP3A4—Calcitriol—osteoporosis	0.00332	0.0155	CbGbCtD
Etonogestrel—CYP3A4—Ergocalciferol—osteoporosis	0.00266	0.0124	CbGbCtD
Etonogestrel—CYP3A4—Raloxifene—osteoporosis	0.00222	0.0104	CbGbCtD
Etonogestrel—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00214	0.01	CbGbCtD
Etonogestrel—CYP3A4—Cholecalciferol—osteoporosis	0.00171	0.008	CbGbCtD
Etonogestrel—CYP3A4—Conjugated Estrogens—osteoporosis	0.00157	0.00734	CbGbCtD
Etonogestrel—CYP3A4—Estradiol—osteoporosis	0.00138	0.00645	CbGbCtD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—ANTXR2—osteoporosis	0.000564	0.127	CbGpPWpGaD
Etonogestrel—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000231	0.0519	CbGpPWpGaD
Etonogestrel—ESR1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000182	0.0408	CbGpPWpGaD
Etonogestrel—Desogestrel—SHBG—osteoporosis	0.000158	0.0909	CrCbGaD
Etonogestrel—PGR—Ovarian Infertility Genes—ESR2—osteoporosis	0.000146	0.0329	CbGpPWpGaD
Etonogestrel—Quinestrol—ESR1—osteoporosis	0.000143	0.082	CrCbGaD
Etonogestrel—PGR—Ovarian Infertility Genes—CYP19A1—osteoporosis	0.000133	0.0299	CbGpPWpGaD
Etonogestrel—Nandrolone phenpropionate—CYP19A1—osteoporosis	0.000132	0.0758	CrCbGaD
Etonogestrel—PGR—Nuclear Receptors—ESR2—osteoporosis	0.000128	0.0287	CbGpPWpGaD
Etonogestrel—PGR—Ovarian Infertility Genes—VDR—osteoporosis	0.000116	0.0261	CbGpPWpGaD
Etonogestrel—Mestranol—ESR1—osteoporosis	0.000108	0.0621	CrCbGaD
Etonogestrel—Desogestrel—ESR1—osteoporosis	0.000107	0.0614	CrCbGaD
Etonogestrel—PGR—Nuclear Receptors—VDR—osteoporosis	0.000101	0.0228	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000101	0.0227	CbGpPWpGaD
Etonogestrel—Nandrolone decanoate—CYP19A1—osteoporosis	9.99e-05	0.0574	CrCbGaD
Etonogestrel—Norgestimate—ESR1—osteoporosis	9.99e-05	0.0574	CrCbGaD
Etonogestrel—Levonorgestrel—SHBG—osteoporosis	9.06e-05	0.052	CrCbGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR2—osteoporosis	8.41e-05	0.0189	CbGpPWpGaD
Etonogestrel—Ethinyl Estradiol—ESR2—osteoporosis	8.37e-05	0.0481	CrCbGaD
Etonogestrel—Danazol—SHBG—osteoporosis	8.25e-05	0.0474	CrCbGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—VDR—osteoporosis	8e-05	0.018	CbGpPWpGaD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—IL1B—osteoporosis	8e-05	0.018	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptors—ESR1—osteoporosis	7.74e-05	0.0174	CbGpPWpGaD
Etonogestrel—Ethinyl Estradiol—SHBG—osteoporosis	7.63e-05	0.0438	CrCbGaD
Etonogestrel—PGR—Nuclear signaling by ERBB4—ESR1—osteoporosis	7.58e-05	0.017	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptors—ESR2—osteoporosis	7.49e-05	0.0168	CbGpPWpGaD
Etonogestrel—Norethindrone—SHBG—osteoporosis	7.34e-05	0.0422	CrCbGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—ESR2—osteoporosis	7.05e-05	0.0158	CbGpPWpGaD
Etonogestrel—Methyltestosterone—SHBG—osteoporosis	6.97e-05	0.04	CrCbGaD
Etonogestrel—Levonorgestrel—CYP19A1—osteoporosis	6.65e-05	0.0382	CrCbGaD
Etonogestrel—ESR1—AP-1 transcription factor network—COL1A2—osteoporosis	6.63e-05	0.0149	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—NFATC1—osteoporosis	6.3e-05	0.0142	CbGpPWpGaD
Etonogestrel—Levonorgestrel—ESR1—osteoporosis	6.12e-05	0.0351	CrCbGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—ESR1—osteoporosis	6.12e-05	0.0138	CbGpPWpGaD
Etonogestrel—Danazol—CYP19A1—osteoporosis	6.05e-05	0.0348	CrCbGaD
Etonogestrel—ESR1—Nuclear Receptors—VDR—osteoporosis	5.94e-05	0.0134	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	5.92e-05	0.0133	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	5.9e-05	0.0133	CbGpPWpGaD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—TNF—osteoporosis	5.81e-05	0.0131	CbGpPWpGaD
Etonogestrel—Danazol—ESR1—osteoporosis	5.57e-05	0.032	CrCbGaD
Etonogestrel—Ethinyl Estradiol—ESR1—osteoporosis	5.15e-05	0.0296	CrCbGaD
Etonogestrel—Methyltestosterone—CYP19A1—osteoporosis	5.12e-05	0.0294	CrCbGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR1—osteoporosis	5.1e-05	0.0115	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—osteoporosis	4.94e-05	0.0111	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—VDR—osteoporosis	4.7e-05	0.0106	CbGpPWpGaD
Etonogestrel—Testosterone—SHBG—osteoporosis	4.04e-05	0.0232	CrCbGaD
Etonogestrel—PGR—Signaling by ERBB4—KL—osteoporosis	3.99e-05	0.00896	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1—osteoporosis	3.7e-05	0.00832	CbGpPWpGaD
Etonogestrel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	3.69e-05	0.00829	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	3.49e-05	0.00785	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	3.24e-05	0.00729	CbGpPWpGaD
Etonogestrel—Testosterone—CYP19A1—osteoporosis	2.97e-05	0.017	CrCbGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	2.93e-05	0.00658	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.89e-05	0.0065	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	2.89e-05	0.0065	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—LEP—osteoporosis	2.76e-05	0.00621	CbGpPWpGaD
Etonogestrel—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	2.76e-05	0.0062	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IRS2—osteoporosis	2.73e-05	0.00614	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	2.65e-05	0.00596	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—ESR1—osteoporosis	2.55e-05	0.00574	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—IRS1—osteoporosis	2.46e-05	0.00554	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IRS1—osteoporosis	2.39e-05	0.00536	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	2.37e-05	0.00534	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KL—osteoporosis	2.34e-05	0.00526	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	2.26e-05	0.00507	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IL6R—osteoporosis	2.24e-05	0.00504	CbGpPWpGaD
Etonogestrel—Angioedema—Conjugated Estrogens—osteoporosis	2.22e-05	0.000284	CcSEcCtD
Etonogestrel—Pharyngitis—Estradiol—osteoporosis	2.21e-05	0.000283	CcSEcCtD
Etonogestrel—Hypersensitivity—Estropipate—osteoporosis	2.21e-05	0.000283	CcSEcCtD
Etonogestrel—Nervous system disorder—Pamidronate—osteoporosis	2.21e-05	0.000283	CcSEcCtD
Etonogestrel—Urinary tract disorder—Estradiol—osteoporosis	2.2e-05	0.000282	CcSEcCtD
Etonogestrel—Vomiting—Etidronic acid—osteoporosis	2.2e-05	0.000282	CcSEcCtD
Etonogestrel—Cough—Zoledronate—osteoporosis	2.2e-05	0.000281	CcSEcCtD
Etonogestrel—Connective tissue disorder—Estradiol—osteoporosis	2.19e-05	0.000281	CcSEcCtD
Etonogestrel—PGR—Gene Expression—U2AF1—osteoporosis	2.19e-05	0.00492	CbGpPWpGaD
Etonogestrel—Urethral disorder—Estradiol—osteoporosis	2.18e-05	0.00028	CcSEcCtD
Etonogestrel—Rash—Etidronic acid—osteoporosis	2.18e-05	0.00028	CcSEcCtD
Etonogestrel—Convulsion—Zoledronate—osteoporosis	2.18e-05	0.000279	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—MYC—osteoporosis	2.18e-05	0.0049	CbGpPWpGaD
Etonogestrel—Dermatitis—Etidronic acid—osteoporosis	2.18e-05	0.000279	CcSEcCtD
Etonogestrel—Hypertension—Zoledronate—osteoporosis	2.17e-05	0.000278	CcSEcCtD
Etonogestrel—Hypersensitivity—Alendronate—osteoporosis	2.17e-05	0.000278	CcSEcCtD
Etonogestrel—Headache—Etidronic acid—osteoporosis	2.17e-05	0.000278	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Risedronate—osteoporosis	2.16e-05	0.000276	CcSEcCtD
Etonogestrel—Asthenia—Estropipate—osteoporosis	2.15e-05	0.000275	CcSEcCtD
Etonogestrel—Visual impairment—Estradiol—osteoporosis	2.15e-05	0.000275	CcSEcCtD
Etonogestrel—Anorexia—Pamidronate—osteoporosis	2.14e-05	0.000275	CcSEcCtD
Etonogestrel—Myalgia—Zoledronate—osteoporosis	2.14e-05	0.000275	CcSEcCtD
Etonogestrel—Arthralgia—Zoledronate—osteoporosis	2.14e-05	0.000275	CcSEcCtD
Etonogestrel—Insomnia—Risedronate—osteoporosis	2.14e-05	0.000274	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—MYC—osteoporosis	2.14e-05	0.00481	CbGpPWpGaD
Etonogestrel—Anxiety—Zoledronate—osteoporosis	2.14e-05	0.000274	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	2.13e-05	0.000273	CcSEcCtD
Etonogestrel—Paraesthesia—Risedronate—osteoporosis	2.12e-05	0.000272	CcSEcCtD
Etonogestrel—Pruritus—Estropipate—osteoporosis	2.12e-05	0.000271	CcSEcCtD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	2.12e-05	0.00476	CbGpPWpGaD
Etonogestrel—Discomfort—Zoledronate—osteoporosis	2.12e-05	0.000271	CcSEcCtD
Etonogestrel—Asthenia—Alendronate—osteoporosis	2.12e-05	0.000271	CcSEcCtD
Etonogestrel—Hypersensitivity—Ibandronate—osteoporosis	2.12e-05	0.000271	CcSEcCtD
Etonogestrel—Cough—Conjugated Estrogens—osteoporosis	2.12e-05	0.000271	CcSEcCtD
Etonogestrel—Convulsion—Conjugated Estrogens—osteoporosis	2.1e-05	0.000269	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	2.1e-05	0.000268	CcSEcCtD
Etonogestrel—Fatigue—Ethinyl Estradiol—osteoporosis	2.09e-05	0.000268	CcSEcCtD
Etonogestrel—Pruritus—Alendronate—osteoporosis	2.09e-05	0.000267	CcSEcCtD
Etonogestrel—Dyspepsia—Risedronate—osteoporosis	2.08e-05	0.000267	CcSEcCtD
Etonogestrel—Eye disorder—Estradiol—osteoporosis	2.08e-05	0.000267	CcSEcCtD
Etonogestrel—Constipation—Ethinyl Estradiol—osteoporosis	2.08e-05	0.000266	CcSEcCtD
Etonogestrel—Hypersensitivity—Calcitriol—osteoporosis	2.07e-05	0.000265	CcSEcCtD
Etonogestrel—Myalgia—Conjugated Estrogens—osteoporosis	2.06e-05	0.000264	CcSEcCtD
Etonogestrel—Arthralgia—Conjugated Estrogens—osteoporosis	2.06e-05	0.000264	CcSEcCtD
Etonogestrel—Asthenia—Ibandronate—osteoporosis	2.06e-05	0.000264	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.06e-05	0.00463	CbGpPWpGaD
Etonogestrel—Anxiety—Conjugated Estrogens—osteoporosis	2.06e-05	0.000263	CcSEcCtD
Etonogestrel—Nausea—Etidronic acid—osteoporosis	2.06e-05	0.000263	CcSEcCtD
Etonogestrel—Oedema—Zoledronate—osteoporosis	2.05e-05	0.000263	CcSEcCtD
Etonogestrel—Anaphylactic shock—Zoledronate—osteoporosis	2.05e-05	0.000263	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	2.05e-05	0.000263	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Pamidronate—osteoporosis	2.05e-05	0.000263	CcSEcCtD
Etonogestrel—Diarrhoea—Estropipate—osteoporosis	2.05e-05	0.000262	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Risedronate—osteoporosis	2.04e-05	0.000262	CcSEcCtD
Etonogestrel—Infection—Zoledronate—osteoporosis	2.04e-05	0.000261	CcSEcCtD
Etonogestrel—Fatigue—Risedronate—osteoporosis	2.04e-05	0.000261	CcSEcCtD
Etonogestrel—Insomnia—Pamidronate—osteoporosis	2.03e-05	0.000261	CcSEcCtD
Etonogestrel—Pruritus—Ibandronate—osteoporosis	2.03e-05	0.00026	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.03e-05	0.00456	CbGpPWpGaD
Etonogestrel—Pain—Risedronate—osteoporosis	2.02e-05	0.000259	CcSEcCtD
Etonogestrel—Constipation—Risedronate—osteoporosis	2.02e-05	0.000259	CcSEcCtD
Etonogestrel—Angiopathy—Estradiol—osteoporosis	2.02e-05	0.000259	CcSEcCtD
Etonogestrel—Paraesthesia—Pamidronate—osteoporosis	2.02e-05	0.000259	CcSEcCtD
Etonogestrel—Diarrhoea—Alendronate—osteoporosis	2.02e-05	0.000258	CcSEcCtD
Etonogestrel—Asthenia—Calcitriol—osteoporosis	2.02e-05	0.000258	CcSEcCtD
Etonogestrel—Nervous system disorder—Zoledronate—osteoporosis	2.02e-05	0.000258	CcSEcCtD
Etonogestrel—Immune system disorder—Estradiol—osteoporosis	2.01e-05	0.000258	CcSEcCtD
Etonogestrel—Feeling abnormal—Ethinyl Estradiol—osteoporosis	2e-05	0.000256	CcSEcCtD
Etonogestrel—Somnolence—Pamidronate—osteoporosis	2e-05	0.000256	CcSEcCtD
Etonogestrel—Skin disorder—Zoledronate—osteoporosis	2e-05	0.000256	CcSEcCtD
Etonogestrel—Pruritus—Calcitriol—osteoporosis	1.99e-05	0.000255	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	1.98e-05	0.000254	CcSEcCtD
Etonogestrel—Diarrhoea—Raloxifene—osteoporosis	1.98e-05	0.000254	CcSEcCtD
Etonogestrel—Dyspepsia—Pamidronate—osteoporosis	1.98e-05	0.000254	CcSEcCtD
Etonogestrel—Dizziness—Estropipate—osteoporosis	1.98e-05	0.000254	CcSEcCtD
Etonogestrel—Anaphylactic shock—Conjugated Estrogens—osteoporosis	1.98e-05	0.000253	CcSEcCtD
Etonogestrel—Oedema—Conjugated Estrogens—osteoporosis	1.98e-05	0.000253	CcSEcCtD
Etonogestrel—Alopecia—Estradiol—osteoporosis	1.97e-05	0.000252	CcSEcCtD
Etonogestrel—Infection—Conjugated Estrogens—osteoporosis	1.97e-05	0.000252	CcSEcCtD
Etonogestrel—Diarrhoea—Ibandronate—osteoporosis	1.96e-05	0.000252	CcSEcCtD
Etonogestrel—Anorexia—Zoledronate—osteoporosis	1.96e-05	0.000251	CcSEcCtD
Etonogestrel—Decreased appetite—Pamidronate—osteoporosis	1.96e-05	0.00025	CcSEcCtD
Etonogestrel—Mental disorder—Estradiol—osteoporosis	1.95e-05	0.00025	CcSEcCtD
Etonogestrel—Dizziness—Alendronate—osteoporosis	1.95e-05	0.00025	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Pamidronate—osteoporosis	1.94e-05	0.000249	CcSEcCtD
Etonogestrel—Nervous system disorder—Conjugated Estrogens—osteoporosis	1.94e-05	0.000249	CcSEcCtD
Etonogestrel—Malnutrition—Estradiol—osteoporosis	1.94e-05	0.000249	CcSEcCtD
Etonogestrel—Erythema—Estradiol—osteoporosis	1.94e-05	0.000249	CcSEcCtD
Etonogestrel—Fatigue—Pamidronate—osteoporosis	1.94e-05	0.000248	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Risedronate—osteoporosis	1.93e-05	0.000248	CcSEcCtD
Etonogestrel—Urticaria—Ethinyl Estradiol—osteoporosis	1.93e-05	0.000247	CcSEcCtD
Etonogestrel—Pain—Pamidronate—osteoporosis	1.92e-05	0.000246	CcSEcCtD
Etonogestrel—Constipation—Pamidronate—osteoporosis	1.92e-05	0.000246	CcSEcCtD
Etonogestrel—Diarrhoea—Calcitriol—osteoporosis	1.92e-05	0.000246	CcSEcCtD
Etonogestrel—Skin disorder—Conjugated Estrogens—osteoporosis	1.92e-05	0.000246	CcSEcCtD
Etonogestrel—Abdominal pain—Ethinyl Estradiol—osteoporosis	1.92e-05	0.000246	CcSEcCtD
Etonogestrel—Body temperature increased—Ethinyl Estradiol—osteoporosis	1.92e-05	0.000246	CcSEcCtD
Etonogestrel—Dizziness—Raloxifene—osteoporosis	1.92e-05	0.000246	CcSEcCtD
Etonogestrel—Flatulence—Estradiol—osteoporosis	1.91e-05	0.000245	CcSEcCtD
Etonogestrel—Tension—Estradiol—osteoporosis	1.9e-05	0.000244	CcSEcCtD
Etonogestrel—Vomiting—Estropipate—osteoporosis	1.9e-05	0.000244	CcSEcCtD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.9e-05	0.00428	CbGpPWpGaD
Etonogestrel—Dizziness—Ibandronate—osteoporosis	1.9e-05	0.000243	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.89e-05	0.00425	CbGpPWpGaD
Etonogestrel—Rash—Estropipate—osteoporosis	1.89e-05	0.000242	CcSEcCtD
Etonogestrel—Dermatitis—Estropipate—osteoporosis	1.89e-05	0.000242	CcSEcCtD
Etonogestrel—Anorexia—Conjugated Estrogens—osteoporosis	1.89e-05	0.000242	CcSEcCtD
Etonogestrel—Nervousness—Estradiol—osteoporosis	1.88e-05	0.000241	CcSEcCtD
Etonogestrel—Urticaria—Risedronate—osteoporosis	1.88e-05	0.000241	CcSEcCtD
Etonogestrel—Back pain—Estradiol—osteoporosis	1.88e-05	0.00024	CcSEcCtD
Etonogestrel—Headache—Estropipate—osteoporosis	1.88e-05	0.00024	CcSEcCtD
Etonogestrel—Vomiting—Alendronate—osteoporosis	1.88e-05	0.00024	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Zoledronate—osteoporosis	1.87e-05	0.00024	CcSEcCtD
Etonogestrel—Abdominal pain—Risedronate—osteoporosis	1.87e-05	0.00024	CcSEcCtD
Etonogestrel—Body temperature increased—Risedronate—osteoporosis	1.87e-05	0.00024	CcSEcCtD
Etonogestrel—Muscle spasms—Estradiol—osteoporosis	1.87e-05	0.000239	CcSEcCtD
Etonogestrel—Rash—Alendronate—osteoporosis	1.86e-05	0.000238	CcSEcCtD
Etonogestrel—Insomnia—Zoledronate—osteoporosis	1.86e-05	0.000238	CcSEcCtD
Etonogestrel—Dermatitis—Alendronate—osteoporosis	1.86e-05	0.000238	CcSEcCtD
Etonogestrel—Feeling abnormal—Pamidronate—osteoporosis	1.85e-05	0.000237	CcSEcCtD
Etonogestrel—Headache—Alendronate—osteoporosis	1.85e-05	0.000237	CcSEcCtD
Etonogestrel—Paraesthesia—Zoledronate—osteoporosis	1.85e-05	0.000236	CcSEcCtD
Etonogestrel—Vomiting—Raloxifene—osteoporosis	1.84e-05	0.000236	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Pamidronate—osteoporosis	1.84e-05	0.000236	CcSEcCtD
Etonogestrel—Rash—Raloxifene—osteoporosis	1.83e-05	0.000234	CcSEcCtD
Etonogestrel—Dermatitis—Raloxifene—osteoporosis	1.83e-05	0.000234	CcSEcCtD
Etonogestrel—Somnolence—Zoledronate—osteoporosis	1.83e-05	0.000234	CcSEcCtD
Etonogestrel—Vomiting—Ibandronate—osteoporosis	1.83e-05	0.000234	CcSEcCtD
Etonogestrel—Headache—Raloxifene—osteoporosis	1.82e-05	0.000233	CcSEcCtD
Etonogestrel—Rash—Ibandronate—osteoporosis	1.81e-05	0.000232	CcSEcCtD
Etonogestrel—Dermatitis—Ibandronate—osteoporosis	1.81e-05	0.000232	CcSEcCtD
Etonogestrel—Dyspepsia—Zoledronate—osteoporosis	1.81e-05	0.000232	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	1.8e-05	0.000231	CcSEcCtD
Etonogestrel—Ill-defined disorder—Estradiol—osteoporosis	1.8e-05	0.000231	CcSEcCtD
Etonogestrel—Headache—Ibandronate—osteoporosis	1.8e-05	0.00023	CcSEcCtD
Etonogestrel—Insomnia—Conjugated Estrogens—osteoporosis	1.79e-05	0.000229	CcSEcCtD
Etonogestrel—Hypersensitivity—Ethinyl Estradiol—osteoporosis	1.79e-05	0.000229	CcSEcCtD
Etonogestrel—Vomiting—Calcitriol—osteoporosis	1.79e-05	0.000229	CcSEcCtD
Etonogestrel—Decreased appetite—Zoledronate—osteoporosis	1.79e-05	0.000229	CcSEcCtD
Etonogestrel—Nausea—Estropipate—osteoporosis	1.78e-05	0.000228	CcSEcCtD
Etonogestrel—Abdominal pain—Pamidronate—osteoporosis	1.78e-05	0.000228	CcSEcCtD
Etonogestrel—Body temperature increased—Pamidronate—osteoporosis	1.78e-05	0.000228	CcSEcCtD
Etonogestrel—Paraesthesia—Conjugated Estrogens—osteoporosis	1.78e-05	0.000228	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Zoledronate—osteoporosis	1.77e-05	0.000227	CcSEcCtD
Etonogestrel—Angioedema—Estradiol—osteoporosis	1.77e-05	0.000227	CcSEcCtD
Etonogestrel—Rash—Calcitriol—osteoporosis	1.77e-05	0.000227	CcSEcCtD
Etonogestrel—Fatigue—Zoledronate—osteoporosis	1.77e-05	0.000227	CcSEcCtD
Etonogestrel—Dermatitis—Calcitriol—osteoporosis	1.77e-05	0.000227	CcSEcCtD
Etonogestrel—Headache—Calcitriol—osteoporosis	1.76e-05	0.000226	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—IL1B—osteoporosis	1.76e-05	0.00396	CbGpPWpGaD
Etonogestrel—Somnolence—Conjugated Estrogens—osteoporosis	1.76e-05	0.000225	CcSEcCtD
Etonogestrel—Pain—Zoledronate—osteoporosis	1.76e-05	0.000225	CcSEcCtD
Etonogestrel—Constipation—Zoledronate—osteoporosis	1.76e-05	0.000225	CcSEcCtD
Etonogestrel—Nausea—Alendronate—osteoporosis	1.75e-05	0.000224	CcSEcCtD
Etonogestrel—Malaise—Estradiol—osteoporosis	1.75e-05	0.000224	CcSEcCtD
Etonogestrel—Hypersensitivity—Risedronate—osteoporosis	1.74e-05	0.000223	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—ESR2—osteoporosis	1.74e-05	0.00392	CbGpPWpGaD
Etonogestrel—Dyspepsia—Conjugated Estrogens—osteoporosis	1.74e-05	0.000223	CcSEcCtD
Etonogestrel—Asthenia—Ethinyl Estradiol—osteoporosis	1.74e-05	0.000223	CcSEcCtD
Etonogestrel—Nausea—Raloxifene—osteoporosis	1.72e-05	0.000221	CcSEcCtD
Etonogestrel—Decreased appetite—Conjugated Estrogens—osteoporosis	1.72e-05	0.00022	CcSEcCtD
Etonogestrel—Pruritus—Ethinyl Estradiol—osteoporosis	1.72e-05	0.00022	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	1.71e-05	0.000219	CcSEcCtD
Etonogestrel—Fatigue—Conjugated Estrogens—osteoporosis	1.71e-05	0.000218	CcSEcCtD
Etonogestrel—Nausea—Ibandronate—osteoporosis	1.71e-05	0.000218	CcSEcCtD
Etonogestrel—Asthenia—Risedronate—osteoporosis	1.7e-05	0.000217	CcSEcCtD
Etonogestrel—Feeling abnormal—Zoledronate—osteoporosis	1.69e-05	0.000217	CcSEcCtD
Etonogestrel—Cough—Estradiol—osteoporosis	1.69e-05	0.000217	CcSEcCtD
Etonogestrel—Constipation—Conjugated Estrogens—osteoporosis	1.69e-05	0.000217	CcSEcCtD
Etonogestrel—Pain—Conjugated Estrogens—osteoporosis	1.69e-05	0.000217	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Zoledronate—osteoporosis	1.68e-05	0.000215	CcSEcCtD
Etonogestrel—Hypertension—Estradiol—osteoporosis	1.68e-05	0.000215	CcSEcCtD
Etonogestrel—Pruritus—Risedronate—osteoporosis	1.67e-05	0.000214	CcSEcCtD
Etonogestrel—Nausea—Calcitriol—osteoporosis	1.67e-05	0.000214	CcSEcCtD
Etonogestrel—Diarrhoea—Ethinyl Estradiol—osteoporosis	1.66e-05	0.000213	CcSEcCtD
Etonogestrel—Hypersensitivity—Pamidronate—osteoporosis	1.66e-05	0.000212	CcSEcCtD
Etonogestrel—Myalgia—Estradiol—osteoporosis	1.65e-05	0.000212	CcSEcCtD
Etonogestrel—Arthralgia—Estradiol—osteoporosis	1.65e-05	0.000212	CcSEcCtD
Etonogestrel—Anxiety—Estradiol—osteoporosis	1.65e-05	0.000211	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—SOST—osteoporosis	1.64e-05	0.00369	CbGpPWpGaD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	1.64e-05	0.00021	CcSEcCtD
Etonogestrel—Urticaria—Zoledronate—osteoporosis	1.63e-05	0.000209	CcSEcCtD
Etonogestrel—Discomfort—Estradiol—osteoporosis	1.63e-05	0.000209	CcSEcCtD
Etonogestrel—PGR—Gene Expression—RPL24—osteoporosis	1.63e-05	0.00366	CbGpPWpGaD
Etonogestrel—Body temperature increased—Zoledronate—osteoporosis	1.62e-05	0.000208	CcSEcCtD
Etonogestrel—Abdominal pain—Zoledronate—osteoporosis	1.62e-05	0.000208	CcSEcCtD
Etonogestrel—Diarrhoea—Risedronate—osteoporosis	1.62e-05	0.000207	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	1.62e-05	0.000207	CcSEcCtD
Etonogestrel—Asthenia—Pamidronate—osteoporosis	1.61e-05	0.000207	CcSEcCtD
Etonogestrel—Dizziness—Ethinyl Estradiol—osteoporosis	1.6e-05	0.000206	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—IRS2—osteoporosis	1.6e-05	0.00361	CbGpPWpGaD
Etonogestrel—Pruritus—Pamidronate—osteoporosis	1.59e-05	0.000204	CcSEcCtD
Etonogestrel—Oedema—Estradiol—osteoporosis	1.58e-05	0.000203	CcSEcCtD
Etonogestrel—Anaphylactic shock—Estradiol—osteoporosis	1.58e-05	0.000203	CcSEcCtD
Etonogestrel—Infection—Estradiol—osteoporosis	1.57e-05	0.000202	CcSEcCtD
Etonogestrel—Urticaria—Conjugated Estrogens—osteoporosis	1.57e-05	0.000201	CcSEcCtD
Etonogestrel—Dizziness—Risedronate—osteoporosis	1.56e-05	0.0002	CcSEcCtD
Etonogestrel—Abdominal pain—Conjugated Estrogens—osteoporosis	1.56e-05	0.0002	CcSEcCtD
Etonogestrel—Body temperature increased—Conjugated Estrogens—osteoporosis	1.56e-05	0.0002	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	1.56e-05	0.0035	CbGpPWpGaD
Etonogestrel—Nervous system disorder—Estradiol—osteoporosis	1.55e-05	0.000199	CcSEcCtD
Etonogestrel—Vomiting—Ethinyl Estradiol—osteoporosis	1.54e-05	0.000198	CcSEcCtD
Etonogestrel—Diarrhoea—Pamidronate—osteoporosis	1.54e-05	0.000197	CcSEcCtD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.54e-05	0.00346	CbGpPWpGaD
Etonogestrel—Skin disorder—Estradiol—osteoporosis	1.54e-05	0.000197	CcSEcCtD
Etonogestrel—Rash—Ethinyl Estradiol—osteoporosis	1.53e-05	0.000196	CcSEcCtD
Etonogestrel—Dermatitis—Ethinyl Estradiol—osteoporosis	1.53e-05	0.000196	CcSEcCtD
Etonogestrel—Headache—Ethinyl Estradiol—osteoporosis	1.52e-05	0.000195	CcSEcCtD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.52e-05	0.00341	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Zoledronate—osteoporosis	1.51e-05	0.000194	CcSEcCtD
Etonogestrel—Vomiting—Risedronate—osteoporosis	1.5e-05	0.000193	CcSEcCtD
Etonogestrel—Rash—Risedronate—osteoporosis	1.49e-05	0.000191	CcSEcCtD
Etonogestrel—Dermatitis—Risedronate—osteoporosis	1.49e-05	0.000191	CcSEcCtD
Etonogestrel—Dizziness—Pamidronate—osteoporosis	1.49e-05	0.000191	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—PTH1R—osteoporosis	1.48e-05	0.00334	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CALCR—osteoporosis	1.48e-05	0.00334	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—osteoporosis	1.48e-05	0.00333	CbGpPWpGaD
Etonogestrel—Headache—Risedronate—osteoporosis	1.48e-05	0.00019	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—TGFB1—osteoporosis	1.48e-05	0.00333	CbGpPWpGaD
Etonogestrel—Asthenia—Zoledronate—osteoporosis	1.47e-05	0.000189	CcSEcCtD
Etonogestrel—Hypersensitivity—Conjugated Estrogens—osteoporosis	1.46e-05	0.000187	CcSEcCtD
Etonogestrel—Pruritus—Zoledronate—osteoporosis	1.45e-05	0.000186	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—osteoporosis	1.45e-05	0.00326	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TGFB1—osteoporosis	1.45e-05	0.00325	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Estradiol—osteoporosis	1.44e-05	0.000185	CcSEcCtD
Etonogestrel—Nausea—Ethinyl Estradiol—osteoporosis	1.44e-05	0.000185	CcSEcCtD
Etonogestrel—Insomnia—Estradiol—osteoporosis	1.43e-05	0.000183	CcSEcCtD
Etonogestrel—Vomiting—Pamidronate—osteoporosis	1.43e-05	0.000183	CcSEcCtD
Etonogestrel—Paraesthesia—Estradiol—osteoporosis	1.42e-05	0.000182	CcSEcCtD
Etonogestrel—Asthenia—Conjugated Estrogens—osteoporosis	1.42e-05	0.000182	CcSEcCtD
Etonogestrel—Rash—Pamidronate—osteoporosis	1.42e-05	0.000182	CcSEcCtD
Etonogestrel—Dermatitis—Pamidronate—osteoporosis	1.42e-05	0.000182	CcSEcCtD
Etonogestrel—Headache—Pamidronate—osteoporosis	1.41e-05	0.000181	CcSEcCtD
Etonogestrel—Somnolence—Estradiol—osteoporosis	1.41e-05	0.00018	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	1.41e-05	0.00316	CbGpPWpGaD
Etonogestrel—Diarrhoea—Zoledronate—osteoporosis	1.41e-05	0.00018	CcSEcCtD
Etonogestrel—Nausea—Risedronate—osteoporosis	1.41e-05	0.00018	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—IRS1—osteoporosis	1.4e-05	0.00315	CbGpPWpGaD
Etonogestrel—Pruritus—Conjugated Estrogens—osteoporosis	1.4e-05	0.000179	CcSEcCtD
Etonogestrel—Dyspepsia—Estradiol—osteoporosis	1.39e-05	0.000179	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—VDR—osteoporosis	1.38e-05	0.00311	CbGpPWpGaD
Etonogestrel—Decreased appetite—Estradiol—osteoporosis	1.38e-05	0.000176	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Estradiol—osteoporosis	1.37e-05	0.000175	CcSEcCtD
Etonogestrel—Fatigue—Estradiol—osteoporosis	1.37e-05	0.000175	CcSEcCtD
Etonogestrel—Dizziness—Zoledronate—osteoporosis	1.36e-05	0.000174	CcSEcCtD
Etonogestrel—Pain—Estradiol—osteoporosis	1.35e-05	0.000173	CcSEcCtD
Etonogestrel—Constipation—Estradiol—osteoporosis	1.35e-05	0.000173	CcSEcCtD
Etonogestrel—Diarrhoea—Conjugated Estrogens—osteoporosis	1.35e-05	0.000173	CcSEcCtD
Etonogestrel—Nausea—Pamidronate—osteoporosis	1.34e-05	0.000171	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—IL6R—osteoporosis	1.32e-05	0.00296	CbGpPWpGaD
Etonogestrel—Dizziness—Conjugated Estrogens—osteoporosis	1.31e-05	0.000168	CcSEcCtD
Etonogestrel—Vomiting—Zoledronate—osteoporosis	1.31e-05	0.000167	CcSEcCtD
Etonogestrel—Feeling abnormal—Estradiol—osteoporosis	1.3e-05	0.000167	CcSEcCtD
Etonogestrel—Rash—Zoledronate—osteoporosis	1.3e-05	0.000166	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Estradiol—osteoporosis	1.29e-05	0.000166	CcSEcCtD
Etonogestrel—Dermatitis—Zoledronate—osteoporosis	1.29e-05	0.000166	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	1.29e-05	0.0029	CbGpPWpGaD
Etonogestrel—Headache—Zoledronate—osteoporosis	1.29e-05	0.000165	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—U2AF1—osteoporosis	1.28e-05	0.00289	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.26e-05	0.00284	CbGpPWpGaD
Etonogestrel—Vomiting—Conjugated Estrogens—osteoporosis	1.26e-05	0.000161	CcSEcCtD
Etonogestrel—Urticaria—Estradiol—osteoporosis	1.26e-05	0.000161	CcSEcCtD
Etonogestrel—Abdominal pain—Estradiol—osteoporosis	1.25e-05	0.00016	CcSEcCtD
Etonogestrel—Body temperature increased—Estradiol—osteoporosis	1.25e-05	0.00016	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—IL6—osteoporosis	1.25e-05	0.00281	CbGpPWpGaD
Etonogestrel—Rash—Conjugated Estrogens—osteoporosis	1.25e-05	0.00016	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.25e-05	0.0028	CbGpPWpGaD
Etonogestrel—Dermatitis—Conjugated Estrogens—osteoporosis	1.25e-05	0.00016	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	1.24e-05	0.0028	CbGpPWpGaD
Etonogestrel—Headache—Conjugated Estrogens—osteoporosis	1.24e-05	0.000159	CcSEcCtD
Etonogestrel—Nausea—Zoledronate—osteoporosis	1.22e-05	0.000156	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—MGLL—osteoporosis	1.18e-05	0.00265	CbGpPWpGaD
Etonogestrel—Nausea—Conjugated Estrogens—osteoporosis	1.18e-05	0.000151	CcSEcCtD
Etonogestrel—Hypersensitivity—Estradiol—osteoporosis	1.17e-05	0.000149	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—LRP5—osteoporosis	1.15e-05	0.00259	CbGpPWpGaD
Etonogestrel—Asthenia—Estradiol—osteoporosis	1.14e-05	0.000146	CcSEcCtD
Etonogestrel—Pruritus—Estradiol—osteoporosis	1.12e-05	0.000143	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—LRP6—osteoporosis	1.1e-05	0.00247	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL6—osteoporosis	1.09e-05	0.00245	CbGpPWpGaD
Etonogestrel—Diarrhoea—Estradiol—osteoporosis	1.08e-05	0.000139	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.08e-05	0.00243	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—ESR1—osteoporosis	1.06e-05	0.00238	CbGpPWpGaD
Etonogestrel—Dizziness—Estradiol—osteoporosis	1.05e-05	0.000134	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—ESR2—osteoporosis	1.02e-05	0.0023	CbGpPWpGaD
Etonogestrel—Vomiting—Estradiol—osteoporosis	1.01e-05	0.000129	CcSEcCtD
Etonogestrel—Rash—Estradiol—osteoporosis	9.98e-06	0.000128	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—IL6—osteoporosis	9.98e-06	0.00224	CbGpPWpGaD
Etonogestrel—Dermatitis—Estradiol—osteoporosis	9.97e-06	0.000128	CcSEcCtD
Etonogestrel—Headache—Estradiol—osteoporosis	9.92e-06	0.000127	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—SOST—osteoporosis	9.63e-06	0.00217	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RPL24—osteoporosis	9.54e-06	0.00215	CbGpPWpGaD
Etonogestrel—Nausea—Estradiol—osteoporosis	9.41e-06	0.00012	CcSEcCtD
Etonogestrel—PGR—Gene Expression—PSMA2—osteoporosis	9.39e-06	0.00211	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PSMA5—osteoporosis	9.39e-06	0.00211	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TLN1—osteoporosis	9.29e-06	0.00209	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.24e-06	0.00208	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTH1R—osteoporosis	8.71e-06	0.00196	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CALCR—osteoporosis	8.71e-06	0.00196	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR2—osteoporosis	8.39e-06	0.00189	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—VDR—osteoporosis	8.11e-06	0.00182	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—P4HB—osteoporosis	8.01e-06	0.0018	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	7.83e-06	0.00176	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTH—osteoporosis	7.8e-06	0.00175	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RAP1A—osteoporosis	7.66e-06	0.00172	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CNR2—osteoporosis	7.6e-06	0.00171	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.49e-06	0.00168	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NFATC1—osteoporosis	7.47e-06	0.00168	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DKK1—osteoporosis	7.41e-06	0.00167	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—WNT1—osteoporosis	7.14e-06	0.00161	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGA—osteoporosis	6.95e-06	0.00156	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MGLL—osteoporosis	6.92e-06	0.00156	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LRP5—osteoporosis	6.75e-06	0.00152	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—VDR—osteoporosis	6.66e-06	0.0015	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	6.62e-06	0.00149	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	6.53e-06	0.00147	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.49e-06	0.00146	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.48e-06	0.00146	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LRP6—osteoporosis	6.46e-06	0.00145	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTHLH—osteoporosis	6.46e-06	0.00145	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BMP2—osteoporosis	6.46e-06	0.00145	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGB—osteoporosis	6.32e-06	0.00142	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PSMA5—osteoporosis	6.1e-06	0.00137	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PSMA2—osteoporosis	6.1e-06	0.00137	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.05e-06	0.00136	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—osteoporosis	5.86e-06	0.00132	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CALCA—osteoporosis	5.69e-06	0.00128	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PSMA2—osteoporosis	5.51e-06	0.00124	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PSMA5—osteoporosis	5.51e-06	0.00124	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—osteoporosis	5.49e-06	0.00124	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TLN1—osteoporosis	5.45e-06	0.00123	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KL—osteoporosis	5.16e-06	0.00116	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR1—osteoporosis	5.09e-06	0.00114	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ESR2—osteoporosis	4.92e-06	0.00111	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—P4HB—osteoporosis	4.7e-06	0.00106	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTH—osteoporosis	4.58e-06	0.00103	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RAP1A—osteoporosis	4.5e-06	0.00101	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CNR2—osteoporosis	4.46e-06	0.001	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NFATC1—osteoporosis	4.39e-06	0.000986	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DKK1—osteoporosis	4.35e-06	0.000978	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—WNT1—osteoporosis	4.19e-06	0.000943	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGA—osteoporosis	4.08e-06	0.000917	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADCY5—osteoporosis	4.05e-06	0.00091	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—POMC—osteoporosis	3.98e-06	0.000895	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SPP1—osteoporosis	3.91e-06	0.00088	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—VDR—osteoporosis	3.91e-06	0.000878	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTHLH—osteoporosis	3.79e-06	0.000852	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BMP2—osteoporosis	3.79e-06	0.000852	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—FDPS—osteoporosis	3.75e-06	0.000844	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PKM—osteoporosis	3.75e-06	0.000844	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGB—osteoporosis	3.71e-06	0.000834	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PSMA2—osteoporosis	3.58e-06	0.000805	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PSMA5—osteoporosis	3.58e-06	0.000805	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PGLS—osteoporosis	3.56e-06	0.0008	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPD2—osteoporosis	3.56e-06	0.0008	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IRS2—osteoporosis	3.54e-06	0.000796	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LEP—osteoporosis	3.46e-06	0.000779	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CALCA—osteoporosis	3.34e-06	0.00075	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ESR1—osteoporosis	3.31e-06	0.000743	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ATIC—osteoporosis	3.26e-06	0.000732	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PNP—osteoporosis	3.26e-06	0.000732	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—osteoporosis	3.22e-06	0.000725	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IRS1—osteoporosis	3.09e-06	0.000695	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KL—osteoporosis	3.03e-06	0.000681	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—POMC—osteoporosis	2.98e-06	0.000669	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6R—osteoporosis	2.9e-06	0.000653	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1—osteoporosis	2.86e-06	0.000643	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA2—osteoporosis	2.77e-06	0.000622	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—OXCT1—osteoporosis	2.77e-06	0.000622	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MGLL—osteoporosis	2.7e-06	0.000606	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—osteoporosis	2.65e-06	0.000595	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADCY5—osteoporosis	2.37e-06	0.000534	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPP1—osteoporosis	2.3e-06	0.000516	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—IDH2—osteoporosis	2.29e-06	0.000516	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.16e-06	0.000485	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ACP5—osteoporosis	2.1e-06	0.000472	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IRS2—osteoporosis	2.08e-06	0.000467	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LEP—osteoporosis	2.03e-06	0.000457	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TPI1—osteoporosis	1.95e-06	0.000438	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—P4HB—osteoporosis	1.83e-06	0.000412	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IRS1—osteoporosis	1.81e-06	0.000408	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GAPDH—osteoporosis	1.8e-06	0.000405	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—RAP1A—osteoporosis	1.75e-06	0.000394	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—POMC—osteoporosis	1.75e-06	0.000393	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—osteoporosis	1.72e-06	0.000387	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—osteoporosis	1.72e-06	0.000386	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6R—osteoporosis	1.7e-06	0.000383	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1—osteoporosis	1.68e-06	0.000378	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—osteoporosis	1.55e-06	0.000349	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENO1—osteoporosis	1.42e-06	0.000319	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PSMA2—osteoporosis	1.4e-06	0.000314	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PSMA5—osteoporosis	1.4e-06	0.000314	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—osteoporosis	1.29e-06	0.000291	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.13e-06	0.000255	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—osteoporosis	1.01e-06	0.000227	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—osteoporosis	1.01e-06	0.000226	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ADCY5—osteoporosis	9.26e-07	0.000208	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPX1—osteoporosis	9.22e-07	0.000207	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—osteoporosis	8.51e-07	0.000191	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—osteoporosis	7.59e-07	0.000171	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—POMC—osteoporosis	6.81e-07	0.000153	CbGpPWpGaD
